Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.

[1]  R. Alexander,et al.  Regulation of the Postsynaptic α‐Adrenergic Receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment 1981 , 1981, Circulation research.

[2]  E. Braunwald,et al.  Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. , 1980, Annals of internal medicine.

[3]  R. Alexander,et al.  Characterization of Postsynaptic Alpha‐Adrenergic Receptors by [8H]‐Dihydroergocryptine Binding in Muscular Arteries from the Rat Mesentery , 1980, Hypertension.

[4]  E. Braunwald,et al.  Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.

[5]  L. Johnson,et al.  Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.

[6]  C. Conti,et al.  Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. , 1979, British heart journal.

[7]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[8]  E. Sonnenblick,et al.  Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.

[9]  W. Pettinger,et al.  Effects of Prazosin and Phentolamine on Arterial Pressure, Heart Rate, and Renin Activity: Evidence in the Conscious Rat for the Functional Significance of the Presynaptic α-Receptor , 1979, Journal of cardiovascular pharmacology.

[10]  B. Brundage,et al.  Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.

[11]  R. Gorlin,et al.  Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.

[12]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[13]  J. Wikberg.  Pharmacological classification of adrenergic α receptors in the guinea pig , 1978, Nature.

[14]  R. Miller,et al.  Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.

[15]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[16]  S. Z. Langer,et al.  Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.

[17]  Oxon Ma.  Gerald Legh Malins McElligott. , 1972 .

[18]  S. Taylor,et al.  Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.